Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-19052025-263206
EXTRAORDINARY
PART II-Section 3-Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 2158]
NEW DELHI, FRIDAY, MAY 16, 2025/VAISAKHA 26, 1947
3228 GI/2025
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health and Family Welfare)
NOTIFICATION
New Delhi the 16th May,2025.
S.O. 2208 (E).—In exercise of the powers conferred by section 6 of the Drugs and
Cosmetics Act, 1940 (23 of 1940) read with clause (a) of sub-rule (1) of rule 19 of the Medical
Devices Rules, 2017 and in supersession of the notification of the Government of India in the
Ministry of Health and Family Welfare number S.O. 3758 (E), dated the 10th August, 2022
published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), except as
respects things done or omitted to be done before such supersession, the Central Government hereby
authorises Dr. Rakesh Kumar Rishi, Director In-charge of Central Drugs Laboratory, Kolkata, to
sign statutory certificates of test or evaluation of samples of Medical Devices sent by Courts of Law
under sub-section (4) of section 25 of the said Act or in Form MD-30 of the Medical Device Rules,
2017, as the Director In-charge of the said laboratory, for the whole of India with effect from the
date of publication of this notification in the Gazette of India till the regularly appointed person
takes charge of the post or until further orders, whichever is earlier.
[F. No. X.11014/2/2025-DR]
RAJIV WADHAWAN, Adviser (Cost).
NOTIFICATION
New Delhi, the 16th May, 2025
S.O. 2209(E).— In exercise of the powers conferred by section 6 of the Drugs and
Cosmetics Act, 1940 (23 of 1940) read with rule 8 of the Drugs Rules, 1945, and in supersession of
the notification of the Government of India in the Ministry of Health and Family Welfare number
S.O. 3757(E), dated 10th August, 2022 published in the Gazette of India, Extraordinary, Part II,
Section 3, Sub-section (ii), except as respects things done or omitted to be done before such
supersession, the Central Government hereby authorises Dr. Rakesh Kumar Rishi, Director In-
charge of Central Drugs Laboratory, Kolkata to sign statutory certificates of test or analysis on the
samples of Drugs and Cosmetics sent by the Courts of Law under sub-section (4) of section 25 of
the said Act or in Form 1 of the Drugs Rules, 1945 as the Director In-charge of Central Drugs
Laboratory, Kolkata for the whole of India with effect from the date of publication of this
notification in the Official Gazette till the regularly appointed person takes charge of the post or
until further orders, whichever is earlier, in respect of all classes of drugs, except the classes of drugs
mentioned below, namely:-
1. Sera
2. Solution of Serum Proteins intended for injection
3. Vaccines
4. Toxins
5. Antigens
6. Anti-toxins
7. Sterilized surgical ligature and sterilized suture
8. Bacteriophages
9. Anti-Sera for Veterinary use
10. Vaccines for Veterinary use
11. Toxoids for Veterinary use
12. Diagnostic Antigens for Veterinary use
13. VDRL Antigen
14. Intra-Uterine Devices and Falope Rings
15. Human Blood and Human Blood Products
16. Blood Grouping reagents and diagnostics kits for Human Immunodeficiency Virus, Hepatitis B
Surface Antigen and Hepatitis C Virus
17. Condoms
[F. No. X.11014/2/2025-DR]
RAJIV WADHAWAN, Adviser (Cost).
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.